Clinical Trial Update: Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating mirikizumab for transmural healing in Crohn's disease; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Mirikizumab (mirikizumab)

Snippet

Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Conditions: Crohn Disease (CD) | Phase 4 | Status: NOT_YET_RECRUITING